This comprehensive review analyzes cutting-edge tools and technologies in modern pharmaceutical research, focusing on ...

Projected return on investment in pharma research and development (R&D) in 2024 has risen to 5.9%, continuing the upward ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

Chetan Pujara, Ph.D Chief Research & Development Officer, SpyGlass Pharma Dr. Pujara brings extensive industry experience to ...

BEIJING - US pharmaceutical giant Pfizer's new research and development (R&D) center officially opened at BioPark in the ...

In addition to a continued focus on growing drug pipelines, and the increasing use of artificial intelligence (AI) and data ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that ...

Big Pharma is expected to see big returns from its investment in a class of drugs made famous by Novo Nordisk’s (NVO) popular ...

The return on investment in pharma research and development (R&D) has increased from the previous year, with GLP-1 drugs ...

Cybercriminals’ tactics have evolved to target sensitive data and disrupt research and development in the pharmaceutical ...

The ongoing conflicts between Ukraine and Russia, as well as Israel and Palestine, have sent ripples across various ...

Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...